The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(1,5-bis(4-Chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)benzene-1,2-diol ID: ALA4283413
PubChem CID: 145991650
Max Phase: Preclinical
Molecular Formula: C21H16Cl2N2O2
Molecular Weight: 399.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1O
Standard InChI: InChI=1S/C21H16Cl2N2O2/c22-15-4-1-13(2-5-15)19-12-18(14-3-10-20(26)21(27)11-14)24-25(19)17-8-6-16(23)7-9-17/h1-11,19,26-27H,12H2
Standard InChI Key: MQKSXCWBYQNCLU-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
30.6328 -22.1722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0717 -22.8609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5553 -23.4954 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7932 -23.1953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8434 -22.3788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2611 -21.8024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4708 -22.0180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8918 -21.4392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1038 -20.6507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8878 -20.4341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4703 -21.0052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0837 -23.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0876 -24.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3806 -24.8332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6708 -24.4252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6685 -23.6123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3740 -23.1959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8904 -22.8609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2986 -22.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1138 -22.1483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5249 -22.8540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1219 -23.5637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3039 -23.5705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5214 -21.4401 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3420 -22.8494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9640 -24.8355 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.5240 -20.0748 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 1 0
7 6 2 0
8 7 1 0
9 8 2 0
10 9 1 0
11 10 2 0
6 11 1 0
4 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
2 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
20 24 1 0
21 25 1 0
15 26 1 0
9 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 399.28Molecular Weight (Monoisotopic): 398.0589AlogP: 5.76#Rotatable Bonds: 3Polar Surface Area: 56.06Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.93CX Basic pKa: 3.60CX LogP: 6.02CX LogD: 6.00Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -0.78
References 1. Abdel-Halim M, Abadi AH, Engel M.. (2018) Design and synthesis of novel 1,3,5-triphenyl pyrazolines as potential anti-inflammatory agents through allosteric inhibition of protein kinase Czeta (PKCζ)., 9 (6): [PMID:30108997 ] [10.1039/C8MD00100F ]